Neuro-fuzzy control for artificial pancreas: in silico development and validation

Type 1 Diabetes Mellitus (DMT1) is currently one of the most harmful diseases that aect people of any age, including children from birth. Exogenous insulin injections remain the most common treatment for these patients, however, it is not the optimal one. The scientific community has endeavored to o...

Full description

Bibliographic Details
Main Authors: Y. Rios, J. García-Rodríguez, E. Sánchez, A. Alanis, E. Ruiz-Velázquez, A. Pardo
Format: Article
Language:Spanish
Published: Universitat Politecnica de Valencia 2020-09-01
Series:Revista Iberoamericana de Automática e Informática Industrial RIAI
Subjects:
Online Access:https://polipapers.upv.es/index.php/RIAI/article/view/13035
id doaj-f97105e214df4355832d0bcea2df5760
record_format Article
spelling doaj-f97105e214df4355832d0bcea2df57602021-04-02T17:55:04ZspaUniversitat Politecnica de ValenciaRevista Iberoamericana de Automática e Informática Industrial RIAI1697-79121697-79202020-09-0117439040010.4995/riai.2020.130358281Neuro-fuzzy control for artificial pancreas: in silico development and validationY. Rios0J. García-Rodríguez1E. Sánchez2A. Alanis3E. Ruiz-Velázquez4A. Pardo5Universidad Tecnológica de BolívarUniversidad de GuadalajaraCINVESTAVUniversidad de GuadalajaraUniversidad de GuadalajaraUniversidad de PamplonaType 1 Diabetes Mellitus (DMT1) is currently one of the most harmful diseases that aect people of any age, including children from birth. Exogenous insulin injections remain the most common treatment for these patients, however, it is not the optimal one. The scientific community has endeavored to optimize insulin administration using electronic devices and thus improve the diabetics life expectancy. There are numerous limitations for this biomedical evolution to become a reality such as the control algorithms validation, experimentation with electronic devices, and applicability in patients age transcendence, among others. This work presents the prototyping of a neuro-fuzzy intelligent controller on the Texas Instruments LAUNCHXL-F28069M development board to form a hardware in the loop (HIL) scheme. That is, the embedded controller sends the insulin delivery rate data to the computer where it is captured by the Uva/Padova software and integrated into the metabolic simulation of virtual diabetic patients treated with an insulin pump. The main task of the embedded intelligent algorithm is to determine the optimal insulin infusion rate for each of the 30 virtual patients who follow a meal protocol. The novelty of this work focuses on overcoming current limitations through a first intelligent control algorithm approach applicable to artificial pancreas (AP) and analyzing the feasibility of this proposal in age transcendence since the results correspond to in-silico tests in populations of 10 adults, 10 adolescents and 10 children.https://polipapers.upv.es/index.php/RIAI/article/view/13035diabetes mellitus tipo 1hardware en el lazocontrolador embebidopáncreas artificial
collection DOAJ
language Spanish
format Article
sources DOAJ
author Y. Rios
J. García-Rodríguez
E. Sánchez
A. Alanis
E. Ruiz-Velázquez
A. Pardo
spellingShingle Y. Rios
J. García-Rodríguez
E. Sánchez
A. Alanis
E. Ruiz-Velázquez
A. Pardo
Neuro-fuzzy control for artificial pancreas: in silico development and validation
Revista Iberoamericana de Automática e Informática Industrial RIAI
diabetes mellitus tipo 1
hardware en el lazo
controlador embebido
páncreas artificial
author_facet Y. Rios
J. García-Rodríguez
E. Sánchez
A. Alanis
E. Ruiz-Velázquez
A. Pardo
author_sort Y. Rios
title Neuro-fuzzy control for artificial pancreas: in silico development and validation
title_short Neuro-fuzzy control for artificial pancreas: in silico development and validation
title_full Neuro-fuzzy control for artificial pancreas: in silico development and validation
title_fullStr Neuro-fuzzy control for artificial pancreas: in silico development and validation
title_full_unstemmed Neuro-fuzzy control for artificial pancreas: in silico development and validation
title_sort neuro-fuzzy control for artificial pancreas: in silico development and validation
publisher Universitat Politecnica de Valencia
series Revista Iberoamericana de Automática e Informática Industrial RIAI
issn 1697-7912
1697-7920
publishDate 2020-09-01
description Type 1 Diabetes Mellitus (DMT1) is currently one of the most harmful diseases that aect people of any age, including children from birth. Exogenous insulin injections remain the most common treatment for these patients, however, it is not the optimal one. The scientific community has endeavored to optimize insulin administration using electronic devices and thus improve the diabetics life expectancy. There are numerous limitations for this biomedical evolution to become a reality such as the control algorithms validation, experimentation with electronic devices, and applicability in patients age transcendence, among others. This work presents the prototyping of a neuro-fuzzy intelligent controller on the Texas Instruments LAUNCHXL-F28069M development board to form a hardware in the loop (HIL) scheme. That is, the embedded controller sends the insulin delivery rate data to the computer where it is captured by the Uva/Padova software and integrated into the metabolic simulation of virtual diabetic patients treated with an insulin pump. The main task of the embedded intelligent algorithm is to determine the optimal insulin infusion rate for each of the 30 virtual patients who follow a meal protocol. The novelty of this work focuses on overcoming current limitations through a first intelligent control algorithm approach applicable to artificial pancreas (AP) and analyzing the feasibility of this proposal in age transcendence since the results correspond to in-silico tests in populations of 10 adults, 10 adolescents and 10 children.
topic diabetes mellitus tipo 1
hardware en el lazo
controlador embebido
páncreas artificial
url https://polipapers.upv.es/index.php/RIAI/article/view/13035
work_keys_str_mv AT yrios neurofuzzycontrolforartificialpancreasinsilicodevelopmentandvalidation
AT jgarciarodriguez neurofuzzycontrolforartificialpancreasinsilicodevelopmentandvalidation
AT esanchez neurofuzzycontrolforartificialpancreasinsilicodevelopmentandvalidation
AT aalanis neurofuzzycontrolforartificialpancreasinsilicodevelopmentandvalidation
AT eruizvelazquez neurofuzzycontrolforartificialpancreasinsilicodevelopmentandvalidation
AT apardo neurofuzzycontrolforartificialpancreasinsilicodevelopmentandvalidation
_version_ 1721552940676677632